文献速递其他结缔组织病

探索干燥综合征临床异质性背后的生物学通路:蛋白质组学与网络分析

Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis.
PubMed 文献 · Ann Rheum Dis · 2024-01-02

研究对180例干燥综合征(SS)患者用O-link技术检测454种血清蛋白,结合网络分析揭示四种临床亚型间趋化因子、细胞因子、TRIM21及代谢相关转录因子表达差异。重新分析托珠单抗III期试验数据发现,仅血清IL-6水平最高的亚型在基线分层后疲劳评分改善。

要点

  • NSST划分的四种SS临床亚型间存在趋化因子、细胞因子和主要自身抗原TRIM21的差异表达。
  • APE1/Ref-1、FOXO1、TIGAR和BACH1等能量代谢与氧化还原相关转录因子在亚型间差异表达。
  • 基线NSST分层后,仅血清IL-6水平最高的亚型在托珠单抗III期试验中疲劳评分改善。

核心结论

  • 数据为SS腺体与非腺体表现的 contributing 通路及不同亚型的潜在治疗靶点提供线索。
  • 分析强调需进一步探索SS亚型背景下的代谢改变和线粒体功能障碍。

研究设计与样本

  • 使用O-link技术对180例SS受试者进行血清蛋白 profiling,采用5个O-link蛋白质组学 panel,共包含454种独特蛋白。
  • 使用ARACNE算法重建网络,并将差异表达估计值叠加于网络以揭示差异表达关键子网络。
  • 重新分析托珠单抗治疗SS的III期试验数据,在基线使用NSST对患者进行分层。

主要发现

  • 分析突出显示SS亚型间趋化因子、细胞因子和主要自身抗原TRIM21的差异表达。
  • 观察到与能量代谢和氧化还原平衡相关的若干转录因子差异表达,即APE1/Ref-1、FOXO1、TIGAR和BACH1。
  • 网络分析中差异表达蛋白相互关联,支持不同分子网络构成SS临床亚型基础的概念。
  • 使用NSST在基线对患者分层后,仅最高血清IL-6水平的亚型显示疲劳评分改善。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需进一步探索SS亚型背景下的代谢改变和线粒体功能障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Stratification approaches are vital to address clinical heterogeneity in Sjogren's syndrome (SS). We previously described that the Newcastle Sjogren's Stratification Tool (NSST) identified four distinct clinical subtypes of SS. We performed proteomic and network analysis to analyse the underlying pathobiology and highlight potential therapeutic targets for different SS subtypes. METHOD: We profiled serum proteins using O-link technology of 180 SS subjects. We used 5 O-link proteomics panels which included a total of 454 unique proteins. Network reconstruction was performed using the ARACNE algorithm, with differential expression estimates overlaid on these networks to reveal the key subnetworks of differential expression. Furthermore, data from a phase III trial of tocilizumab in SS were reanalysed by stratifying patients at baseline using NSST. RESULTS: Our analysis highlights differential expression of chemokines, cytokines and the major autoantigen TRIM21 between the SS subtypes. Furthermore, we observe differential expression of several transcription factors associated with energy metabolism and redox balance namely APE1/Ref-1, FOXO1, TIGAR and BACH1. The differentially expressed proteins were inter-related in our network analysis, supporting the concept that distinct molecular networks underlie the clinical subtypes of SS. Stratification of patients at baseline using NSST revealed improvement of fatigue score only in the subtype expressing the highest levels of serum IL-6. CONCLUSIONS: Our data provide clues to the pathways contributing to the glandular and non-glandular manifestations of SS and to potential therapeutic targets for different SS subtypes. In addition, our analysis highlights the need for further exploration of altered metabolism and mitochondrial dysfunction in the context of SS subtypes.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Berry JS, Tarn J, Casement J, et al. Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis. Ann Rheum Dis. 2024. PMID: 37657927. doi:10.1136/ard-2023-224503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。